Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice

Atherosclerosis

Volumn 143, Issue 1, 1999, Pages 205-211

  C Dawson, Tracey ^a   A Kuziel, William ^b   A Osahar, Tene ^a   Maeda, Nobuyo ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Atherogenesis; Chemotaxis; Knockout mice; MCP 1; Monocytes

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHEMOTAXIS; CONTROLLED STUDY; KNOCKOUT MOUSE; LIPID BLOOD LEVEL; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHEMOKINE CCL2; FEMALE; LIPIDS; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, CHEMOKINE;

EID: 0033060017     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00318-9     Document Type: Article

References (41)

1. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 57:1995;791-804.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
3. Fan J., Shimokama T., Haraoka S., Tokunaga O., Watanabe T. Monocyte endothelial cell interactions in vitro, with reference to the influence of interleukin-1 and tumor necrosis factor. Biol Cell. 79:1993;17-26.
4. Cybulsky J.I., Gimbrone M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 251:1991;788-791.
5. Kume N., Cybulsky M.I., Gimbrone M.A. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 90:1992;1138-1144.
6. Lu B., Rutledge B.J., Gu L. et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med. 187:1998;601-608.
7. Kuziel W.A., Morgan S.J., Dawson T.C. et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA. 94:1997;12053-12058.
8. Kurihara T., Warr G., Loy J., Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med. 186:1997;1757-1762.
9. Boring L., Gosling J., Chensue S.W. et al. Impaired monocyte migration and reduces type 1 (Th1) cytokine responses in CC chemokine receptor 2 knockout mice. J Clin Invest. 100:1997;2552-2561.
10. Takeya M., Yoshimura T., Leonard E.J., Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol. 24:1993;534-539.
11. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E. et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA. 88:1991;5252-5256.
12. Nelken N.A., Coughlin S.R., Gordon D., Wilcox J.N. Monocyte chemoattractant proteins-1 in human atheromatous plaques. J Clin Invest. 88:1991;1121-1127.
13. Russell M.E., Adams D.H., Wyner L.R., Yamashita Y., Halnon N.J., Karnovsky M.J. Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts. Proc Natl Acad Sci USA. 90:1993;6086-6090.
14. Cushing S.D., Berliner J.A., Valente A.J. et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA. 87:1990;5134-5138.
15. Wang G.P., Deng Z.D., Ni J., Qu Z.L. Oxidized low density lipoprotein and very low density lipoprotein enhance expression of monocyte chemoattractant protein-1 in rabbit peritoneal exudate macrophages. Atherosclerosis. 133:1997;31-36.
16. Lukacs N.W., Strieter R.M., Elner V., Evanoff H.L., Burdick M.D., Kunkel S.L. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions. Blood. 86:1995;2767-2773.
17. Navab M., Imes S.S., Hama S.Y. et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 88:1991;2039-2046.
18. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P.M., Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA. 89:1992;4471-4475.
19. Plump A.S., Smith J.D., Hayek T. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
20. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:1992;468-471.
21. Smith J.D., Trogan E., Ginsberg M., Grigaux C., Tian J., Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA. 92:1995;8264-8268.
22. Xiao Q., Danton M.J.S., Witte D.P. et al. Plasminogen deficiency accelerates vessel was disease in mice predisposed to atherosclerosis. Proc Natl Acad Sci USA. 94:1997;10335-10340.
23. Suzuki H., Kurlhara Y., Takeya M. et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 386:1997;292-296.
24. Paigen B., Morrow A., Holmes P.A., Mitchell D., Williams R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68:1987;231-240.
25. Zhang S.H., Reddick R.L., Burkey B., Maeda N. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest. 94:1994;937-945.
26. Reddick R.L., Zhang S.H., Maeda N. Atherosclerosis in mice lacking Apo E: evaluation of lesional development and progression. Arterioscler Thromb. 14:1994;141-147.
27. Smithies O., Maeda N. Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension. Proc Natl Acad Sci USA. 92:1995;5266-5272.
28. Gibbons G.H., Dzau V.J. Molecular therapies for vascular diseases. Science. 272:1996;689-693.
29. Libby P., Sukhova G., Lee R.T., Galis Z.S. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol. 25(Suppl 2):1995;S9-S12.
30. Qiao J., Tripathi J., Mishra N.K. et al. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am J Pathol. 150:1997;1687-1699.
31. Gu L., Okada Y., Clinton S.K. et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 2:1998;275-281.
32. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:1998;894-897.
33. Galis Z.S., Muszynski M., Sukhova G.K. et al. Cytokine-stimulated human vascular smooth-muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 75:1994;181-189.
34. Morohashi H., Miyawaki T., Nomura H. et al. Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J Leuk Biol. 57:1995;180-187.
35. Qin S., LaRosa G., Campbell J.J. et al. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential. Eur J Immunol. 26:1996;640-647.
36. Wang N., Tabas I., Winchester R., Ravalli S., Rabbani L.E., Tall A. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem. 271:1996;8837-8842.
37. Apostolopoulos J., Davenport P., Tipping P.G. Interleukin 8 production by macrophages from atheromatous plaques. Arterioscler Thromb Vasc Biol. 16:1996;1007-1012.
38. Terkeltaub R., Banka C., Solan J., Santoro D., Brand K., Curtiss L.K. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T lymphocyte chemotactic activity. Arterioscler Thromb Vasc Biol. 14:1994;47-53.
39. Boisvert W.A., Santiago R., Curtiss L.K., Terkeltaub R.A. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest. 101:1998;353-363.
40. Marks S.C., Lane P.W. Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J Hered. 67:1967;11-18.
41. Cacalano G., Lee J., Kikly K. et al. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science. 265:1994;682-684.